Global and China Dysmenorrhea Treatment Market Size, Status and Forecast 2024-2031

Report ID: 1025259 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dysmenorrhea Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Pain Relievers
        1.2.3 Hormonal Therapy
        1.2.4 Surgery
    1.3 Market by Application
        1.3.1 Global Dysmenorrhea Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Dysmenorrhea Treatment Market Perspective (2016-2027)
    2.2 Dysmenorrhea Treatment Growth Trends by Regions
        2.2.1 Dysmenorrhea Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Dysmenorrhea Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Dysmenorrhea Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Dysmenorrhea Treatment Industry Dynamic
        2.3.1 Dysmenorrhea Treatment Market Trends
        2.3.2 Dysmenorrhea Treatment Market Drivers
        2.3.3 Dysmenorrhea Treatment Market Challenges
        2.3.4 Dysmenorrhea Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Dysmenorrhea Treatment Players by Revenue
        3.1.1 Global Top Dysmenorrhea Treatment Players by Revenue (2016-2021)
        3.1.2 Global Dysmenorrhea Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Dysmenorrhea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Dysmenorrhea Treatment Revenue
    3.4 Global Dysmenorrhea Treatment Market Concentration Ratio
        3.4.1 Global Dysmenorrhea Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dysmenorrhea Treatment Revenue in 2020
    3.5 Dysmenorrhea Treatment Key Players Head office and Area Served
    3.6 Key Players Dysmenorrhea Treatment Product Solution and Service
    3.7 Date of Enter into Dysmenorrhea Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Dysmenorrhea Treatment Breakdown Data by Type
    4.1 Global Dysmenorrhea Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Dysmenorrhea Treatment Forecasted Market Size by Type (2022-2027)

5 Dysmenorrhea Treatment Breakdown Data by Application
    5.1 Global Dysmenorrhea Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Dysmenorrhea Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Dysmenorrhea Treatment Market Size (2016-2027)
    6.2 North America Dysmenorrhea Treatment Market Size by Type
        6.2.1 North America Dysmenorrhea Treatment Market Size by Type (2016-2021)
        6.2.2 North America Dysmenorrhea Treatment Market Size by Type (2022-2027)
        6.2.3 North America Dysmenorrhea Treatment Market Size by Type (2016-2027)
    6.3 North America Dysmenorrhea Treatment Market Size by Application
        6.3.1 North America Dysmenorrhea Treatment Market Size by Application (2016-2021)
        6.3.2 North America Dysmenorrhea Treatment Market Size by Application (2022-2027)
        6.3.3 North America Dysmenorrhea Treatment Market Size by Application (2016-2027)
    6.4 North America Dysmenorrhea Treatment Market Size by Country
        6.4.1 North America Dysmenorrhea Treatment Market Size by Country (2016-2021)
        6.4.2 North America Dysmenorrhea Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Dysmenorrhea Treatment Market Size (2016-2027)
    7.2 Europe Dysmenorrhea Treatment Market Size by Type
        7.2.1 Europe Dysmenorrhea Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Dysmenorrhea Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Dysmenorrhea Treatment Market Size by Type (2016-2027)
    7.3 Europe Dysmenorrhea Treatment Market Size by Application
        7.3.1 Europe Dysmenorrhea Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Dysmenorrhea Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Dysmenorrhea Treatment Market Size by Application (2016-2027)
    7.4 Europe Dysmenorrhea Treatment Market Size by Country
        7.4.1 Europe Dysmenorrhea Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Dysmenorrhea Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Dysmenorrhea Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Dysmenorrhea Treatment Market Size by Type
        8.2.1 Asia-Pacific Dysmenorrhea Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Dysmenorrhea Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Dysmenorrhea Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Dysmenorrhea Treatment Market Size by Application
        8.3.1 Asia-Pacific Dysmenorrhea Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Dysmenorrhea Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Dysmenorrhea Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Dysmenorrhea Treatment Market Size by Region
        8.4.1 Asia-Pacific Dysmenorrhea Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Dysmenorrhea Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Dysmenorrhea Treatment Market Size (2016-2027)
    9.2 Latin America Dysmenorrhea Treatment Market Size by Type
        9.2.1 Latin America Dysmenorrhea Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Dysmenorrhea Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Dysmenorrhea Treatment Market Size by Type (2016-2027)
    9.3 Latin America Dysmenorrhea Treatment Market Size by Application
        9.3.1 Latin America Dysmenorrhea Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Dysmenorrhea Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Dysmenorrhea Treatment Market Size by Application (2016-2027)
    9.4 Latin America Dysmenorrhea Treatment Market Size by Country
        9.4.1 Latin America Dysmenorrhea Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Dysmenorrhea Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Dysmenorrhea Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Type
        10.2.1 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Application
        10.3.1 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Dysmenorrhea Treatment Market Size by Country
        10.4.1 Middle East & Africa Dysmenorrhea Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Dysmenorrhea Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Merck & Co.
        11.1.1 Merck & Co. Company Details
        11.1.2 Merck & Co. Business Overview
        11.1.3 Merck & Co. Dysmenorrhea Treatment Introduction
        11.1.4 Merck & Co. Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.1.5 Merck & Co. Recent Development
    11.2 Novartis AG
        11.2.1 Novartis AG Company Details
        11.2.2 Novartis AG Business Overview
        11.2.3 Novartis AG Dysmenorrhea Treatment Introduction
        11.2.4 Novartis AG Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.2.5 Novartis AG Recent Development
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Bayer Business Overview
        11.3.3 Bayer Dysmenorrhea Treatment Introduction
        11.3.4 Bayer Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.3.5 Bayer Recent Development
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Dysmenorrhea Treatment Introduction
        11.4.4 Abbott Laboratories Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.4.5 Abbott Laboratories Recent Development
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Dysmenorrhea Treatment Introduction
        11.5.4 Pfizer Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.5.5 Pfizer Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Dysmenorrhea Treatment Introduction
        11.6.4 Roche Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.6.5 Roche Recent Development
    11.7 TAJ Pharma
        11.7.1 TAJ Pharma Company Details
        11.7.2 TAJ Pharma Business Overview
        11.7.3 TAJ Pharma Dysmenorrhea Treatment Introduction
        11.7.4 TAJ Pharma Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.7.5 TAJ Pharma Recent Development
    11.8 Mylan Pharmaceuticals
        11.8.1 Mylan Pharmaceuticals Company Details
        11.8.2 Mylan Pharmaceuticals Business Overview
        11.8.3 Mylan Pharmaceuticals Dysmenorrhea Treatment Introduction
        11.8.4 Mylan Pharmaceuticals Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.8.5 Mylan Pharmaceuticals Recent Development
    11.9 Nobel Pharmaceuticals
        11.9.1 Nobel Pharmaceuticals Company Details
        11.9.2 Nobel Pharmaceuticals Business Overview
        11.9.3 Nobel Pharmaceuticals Dysmenorrhea Treatment Introduction
        11.9.4 Nobel Pharmaceuticals Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.9.5 Nobel Pharmaceuticals Recent Development
    11.10 Juniper Pharmaceuticals
        11.10.1 Juniper Pharmaceuticals Company Details
        11.10.2 Juniper Pharmaceuticals Business Overview
        11.10.3 Juniper Pharmaceuticals Dysmenorrhea Treatment Introduction
        11.10.4 Juniper Pharmaceuticals Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.10.5 Juniper Pharmaceuticals Recent Development
    11.11 Sanofi
        11.11.1 Sanofi Company Details
        11.11.2 Sanofi Business Overview
        11.11.3 Sanofi Dysmenorrhea Treatment Introduction
        11.11.4 Sanofi Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.11.5 Sanofi Recent Development
    11.12 GlaxoSmithKline
        11.12.1 GlaxoSmithKline Company Details
        11.12.2 GlaxoSmithKline Business Overview
        11.12.3 GlaxoSmithKline Dysmenorrhea Treatment Introduction
        11.12.4 GlaxoSmithKline Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.12.5 GlaxoSmithKline Recent Development
    11.13 Johnson & Johnson
        11.13.1 Johnson & Johnson Company Details
        11.13.2 Johnson & Johnson Business Overview
        11.13.3 Johnson & Johnson Dysmenorrhea Treatment Introduction
        11.13.4 Johnson & Johnson Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.13.5 Johnson & Johnson Recent Development
    11.14 Focus Consumer Healthcare
        11.14.1 Focus Consumer Healthcare Company Details
        11.14.2 Focus Consumer Healthcare Business Overview
        11.14.3 Focus Consumer Healthcare Dysmenorrhea Treatment Introduction
        11.14.4 Focus Consumer Healthcare Revenue in Dysmenorrhea Treatment Business (2016-2021)
        11.14.5 Focus Consumer Healthcare Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Dysmenorrhea Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Pain Relievers
    Table 3. Key Players of Hormonal Therapy
    Table 4. Key Players of Surgery
    Table 5. Global Dysmenorrhea Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Dysmenorrhea Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Dysmenorrhea Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Dysmenorrhea Treatment Market Share by Regions (2016-2021)
    Table 9. Global Dysmenorrhea Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Dysmenorrhea Treatment Market Share by Regions (2022-2027)
    Table 11. Dysmenorrhea Treatment Market Trends
    Table 12. Dysmenorrhea Treatment Market Drivers
    Table 13. Dysmenorrhea Treatment Market Challenges
    Table 14. Dysmenorrhea Treatment Market Restraints
    Table 15. Global Dysmenorrhea Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Dysmenorrhea Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Dysmenorrhea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dysmenorrhea Treatment as of 2020)
    Table 18. Ranking of Global Top Dysmenorrhea Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Dysmenorrhea Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Dysmenorrhea Treatment Product Solution and Service
    Table 22. Date of Enter into Dysmenorrhea Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Dysmenorrhea Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Dysmenorrhea Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Dysmenorrhea Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Dysmenorrhea Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Dysmenorrhea Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Dysmenorrhea Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Dysmenorrhea Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Dysmenorrhea Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Dysmenorrhea Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Dysmenorrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Dysmenorrhea Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Dysmenorrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Dysmenorrhea Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Dysmenorrhea Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Dysmenorrhea Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Dysmenorrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Dysmenorrhea Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Dysmenorrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Dysmenorrhea Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Dysmenorrhea Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Dysmenorrhea Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Dysmenorrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Dysmenorrhea Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Dysmenorrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Dysmenorrhea Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Dysmenorrhea Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Dysmenorrhea Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Dysmenorrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Dysmenorrhea Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Dysmenorrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Dysmenorrhea Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Dysmenorrhea Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Dysmenorrhea Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Dysmenorrhea Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Dysmenorrhea Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Dysmenorrhea Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Merck & Co. Company Details
    Table 63. Merck & Co. Business Overview
    Table 64. Merck & Co. Dysmenorrhea Treatment Product
    Table 65. Merck & Co. Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 66. Merck & Co. Recent Development
    Table 67. Novartis AG Company Details
    Table 68. Novartis AG Business Overview
    Table 69. Novartis AG Dysmenorrhea Treatment Product
    Table 70. Novartis AG Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 71. Novartis AG Recent Development
    Table 72. Bayer Company Details
    Table 73. Bayer Business Overview
    Table 74. Bayer Dysmenorrhea Treatment Product
    Table 75. Bayer Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 76. Bayer Recent Development
    Table 77. Abbott Laboratories Company Details
    Table 78. Abbott Laboratories Business Overview
    Table 79. Abbott Laboratories Dysmenorrhea Treatment Product
    Table 80. Abbott Laboratories Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 81. Abbott Laboratories Recent Development
    Table 82. Pfizer Company Details
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Dysmenorrhea Treatment Product
    Table 85. Pfizer Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 86. Pfizer Recent Development
    Table 87. Roche Company Details
    Table 88. Roche Business Overview
    Table 89. Roche Dysmenorrhea Treatment Product
    Table 90. Roche Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 91. Roche Recent Development
    Table 92. TAJ Pharma Company Details
    Table 93. TAJ Pharma Business Overview
    Table 94. TAJ Pharma Dysmenorrhea Treatment Product
    Table 95. TAJ Pharma Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 96. TAJ Pharma Recent Development
    Table 97. Mylan Pharmaceuticals Company Details
    Table 98. Mylan Pharmaceuticals Business Overview
    Table 99. Mylan Pharmaceuticals Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 100. Mylan Pharmaceuticals Recent Development
    Table 101. Nobel Pharmaceuticals Company Details
    Table 102. Nobel Pharmaceuticals Business Overview
    Table 103. Nobel Pharmaceuticals Dysmenorrhea Treatment Product
    Table 104. Nobel Pharmaceuticals Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 105. Nobel Pharmaceuticals Recent Development
    Table 106. Juniper Pharmaceuticals Company Details
    Table 107. Juniper Pharmaceuticals Business Overview
    Table 108. Juniper Pharmaceuticals Dysmenorrhea Treatment Product
    Table 109. Juniper Pharmaceuticals Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 110. Juniper Pharmaceuticals Recent Development
    Table 111. Sanofi Company Details
    Table 112. Sanofi Business Overview
    Table 113. Sanofi Dysmenorrhea Treatment Product
    Table 114. Sanofi Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 115. Sanofi Recent Development
    Table 116. GlaxoSmithKline Company Details
    Table 117. GlaxoSmithKline Business Overview
    Table 118. GlaxoSmithKline Dysmenorrhea Treatment Product
    Table 119. GlaxoSmithKline Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 120. GlaxoSmithKline Recent Development
    Table 121. Johnson & Johnson Company Details
    Table 122. Johnson & Johnson Business Overview
    Table 123. Johnson & Johnson Dysmenorrhea Treatment Product
    Table 124. Johnson & Johnson Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 125. Johnson & Johnson Recent Development
    Table 126. Focus Consumer Healthcare Company Details
    Table 127. Focus Consumer Healthcare Business Overview
    Table 128. Focus Consumer Healthcare Dysmenorrhea Treatment Product
    Table 129. Focus Consumer Healthcare Revenue in Dysmenorrhea Treatment Business (2016-2021) & (US$ Million)
    Table 130. Focus Consumer Healthcare Recent Development
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dysmenorrhea Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Pain Relievers Features
    Figure 3. Hormonal Therapy Features
    Figure 4. Surgery Features
    Figure 5. Global Dysmenorrhea Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Research Centers Case Studies
    Figure 9. Others Case Studies
    Figure 10. Dysmenorrhea Treatment Report Years Considered
    Figure 11. Global Dysmenorrhea Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Dysmenorrhea Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Dysmenorrhea Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Dysmenorrhea Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Dysmenorrhea Treatment Market Share by Players in 2020
    Figure 16. Global Top Dysmenorrhea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dysmenorrhea Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Dysmenorrhea Treatment Revenue in 2020
    Figure 18. Global Dysmenorrhea Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Dysmenorrhea Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Dysmenorrhea Treatment Market Share by Type (2016-2027)
    Figure 22. North America Dysmenorrhea Treatment Market Share by Application (2016-2027)
    Figure 23. North America Dysmenorrhea Treatment Market Share by Country (2016-2027)
    Figure 24. United States Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Dysmenorrhea Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Dysmenorrhea Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Dysmenorrhea Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Dysmenorrhea Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Dysmenorrhea Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Dysmenorrhea Treatment Market Share by Region (2016-2027)
    Figure 40. China Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Dysmenorrhea Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Dysmenorrhea Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Dysmenorrhea Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Dysmenorrhea Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Dysmenorrhea Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Dysmenorrhea Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Dysmenorrhea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Merck & Co. Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 60. Novartis AG Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 61. Bayer Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 62. Abbott Laboratories Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 63. Pfizer Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 64. Roche Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 65. TAJ Pharma Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 66. Mylan Pharmaceuticals Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 67. Nobel Pharmaceuticals Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 68. Juniper Pharmaceuticals Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 69. Sanofi Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 70. GlaxoSmithKline Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 71. Johnson & Johnson Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 72. Focus Consumer Healthcare Revenue Growth Rate in Dysmenorrhea Treatment Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.
Novartis AG
Bayer
Abbott Laboratories
Pfizer
Roche
TAJ Pharma
Mylan Pharmaceuticals
Nobel Pharmaceuticals
Juniper Pharmaceuticals
Sanofi
GlaxoSmithKline
Johnson & Johnson
Focus Consumer Healthcare
Frequently Asked Questions
Dysmenorrhea Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dysmenorrhea Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dysmenorrhea Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports